Mobile app helps to track breast cancer survivors' experiences
the ONA take:
A new patient-centered mobile app and interactive research study, entitled Share the Journey: Mind, Body and Wellness after Breast Cancer, has launched.
The app is open for American women of ages is open to women of ages 18 through 80 (regardless of their breast cancer status) and acts as a repository of participant feedback on breast cancer and health experiences via well-validated surveys, symptom reporting, and more.
Cancer survivors can share their experiences through the app, and add to the data collected at the same time.
UCLA cancer research pioneer Dr. Patricia Ganz, currently director of cancer prevention and control research at the Jonsson Cancer Center, was a principal collaborator, in conjunction with UCLA's Jonsson Comprehensive Cancer Center, Penn Medicine, Sage Bionetworks, and the Dana-Farber Cancer Institute.
One of the goals of this project is to collect information on negative treatment effects and elements of the survivors experience more easily missed during infrequent doctor visits.
Via Share the Journey, survivors of breast cancer can participate as data owners and take a more active role in steering treatment and research directions. The information is vital for researchers and will help them more fully understand the patient experience and analyze recovery patterns.
Share the Journey is being launched in conjunction with Apple's ResearchKit. More information about Share the Journey may be found here: http://sharethejourneyapp.org/.
Increase in brain tumors is not attributed to mobile phone use
Sign Up for Free e-newsletters
- Leukemia Risk in Children, Maternal Use of Hormonal Contraception Linked in Population Study
- Hodgkin Lymphoma Survivorship Marked by Periods of Actionable Distress
- Medication, Vaccination Uptake Improved by Involving Pharmacists in Elder Cancer Care
- Molecular Features May Predict Response in Primary Pancreatic Cancer
- Stem Cell Transplantation Superior to Chemotherapy for Relapsed/Refractory DLBCL, Follicular Lymphoma
- Navigating Prostate Cancer: A Patient's Experience From Diagnosis to Survivor
- Cell Phones and Cancer Risk (Fact Sheet)
- How Likely Are Oncologists to Refer for Palliative Care? Depends on Their Age
- Use of Corticosteroids With PD-1 or PD-L1 Inhibitors Associated With Poorer Outcomes in NSCLC
- Chemoimmunotherapy Increases Survival in Triple-Negative Breast Cancer
- Integrative Medicine in Childhood Cancer: Practices That Can Help Pediatric Patients
- Clinical Characteristics That Increase Risk of Chemotherapy-Induced Febrile Neutropenia Identified
- Dose-Escalation Mitigates Risk of Grade 3/4 Adverse Events With Ruxolitinib for Myelofibrosis
- Counseling Patients on Oral Chemotherapy
- Patients and Caregivers Worry About Cost of Cancer Care
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|